Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Where's the PR on patent application 17/215,589 Tom?
Both 510k and patent were rejected 17 months ago and the stock was left for dead.
Trying to pass off a share price increase as being driven by company fundamentals when it was the inept management that drove it into the ground in the first place, is misleading to put it mildly.
I suppose I should update my last post… up 1800% in last 17 months… keep spewing nonsense the SP is what determines the gains of investors and nobody is listening to references from 2015, 2017, or any other nonsense.
The future is now and that’s debt free with positive cash flow
1200% return on investment in the last 17 months… keep saying what you want but this ticker consistently give returns to its investors!
There's a patent pending for something related to the DeltaWave and whatever it is should have been disclosed to shareholders.
There is no disclosure because there truly isn’t a pending patent for the second device yet… smh
Team Tsunami
For all the haters out there… company is debt free and has positive cash flows… sure the SP isn’t at the 52 week high as a result of the FDA delay.
However compared to 99% of other tickers… being up 41.86% on the year to date is actually very impressive.
Day to day pricing plus with your emotions especially for those who are flipping or trading this stock…
For long term investors day to day is entertaining to watch but not stressful as the bigger picture is as good of a set up as you will ever find!
Learn to Ride the wave!
No disclosure from CEO on this pending patent.
You have shared that the original patent was partially withdrawn and needed to be resubmitted… sounds almost like the process for 510k…
Oh yeah that’s right they succeeded in final submission and received a 20 year US patent approval on April 27 2021.
I hate that I have to break this down further but the final patent number is not the same as the application number…
The past does not define the future for a Company that is debt free and has a positive cash flow.
Team Tsunami has over 4,162 investors!
I will say it again for those who cannot read. The DeltaWave has a 20 year U.S. patent. There is not a second patent approved or applied for regarding the second mask that was talked about in RMSL recent PR’s it’s a beautiful mystery as to what the second mask actually is. Anybody claiming otherwise thinks they know more then there is to know!
Not to mention let’s make up fake news that a new patent has been applied for when it hasn’t been.
So a company that is debt free on the otc and has positive cash flow… Yupp let’s go back and talk about the 20 year US patent that was approved and issued… what a joke.
Somebody is impatient… first it was DeltaWave isn’t impressive now it’s a piggy bank patent… I do not see any information on recent updates or applications for the second mask. This leads me to believe a patent has not been applied for yet… just as a second 510k hasn’t been applied for yet…
The second mask won’t need to be patent approved for a second 510k application to take place. RemSleep seems to be focused on DeltaWave first and then I am sure we will get further clarification on what the second mask design is and the timeline on that product.
Not exactly earth shattering. The only patent pending application for Remsleep Holdings Inc.
Who owns the patent to the second mask?
If it's Tom's patent it should have been blasted on the front cover of the latest PRs. Sounds like it's another one of those third party knock-offs from "overseas" aka China.
Third party knock-offs are a far cry from "revolutionary".
Excellent post ??
Show me another otc ticker with no debt, positive cash flow, two revolutionary products….
I’ll wait…. And I’ll wait for a long time… it doesn’t exist…
So yes FDA withdrawal and resubmission will take a few extra months but that’s okay considering the set up of the company!
Suck up tweet on old news to divert attention from Tom letting the cat out the bag that he plans on forking out a half billion shares.
Anybody who actually reads the filings would know that there was only one note left on the books last quarter.
What folks should have been asking was why Tom didn't spare shareholders the unnecessary dilution and pay them off when he had the cash instead of allowing them to convert.
Buy time before the 2’s
Remsleep Holdings Inc
@RemsleepInc
·
3m
We are proud to announce that we have paid off our last remaining debt on our balance sheets. So, as of today, we are 100% completely debt free. We also do not have any remaining convertible debt. $RMSL
We are proud to announce that we have paid off our last remaining debt on our balance sheets. So, as of today, we are 100% completely debt free. We also do not have any remaining convertible debt. $RMSL
— Remsleep Holdings Inc (@RemsleepInc) June 17, 2022
What a joke… they clarified there will not be dilution… yet he still claims it’s going to happen..
Non event now, move on.
The S-1 filing SUGGESTED the dilution.
Agree, I emailed Tom yesterday and again today in relation to what had taken place and the necessity to provide update to shareholders re why this was done. I am sure I was one of many who did this. Was great to see such a comprehensive PR as to what had taken place. Good on Tom for doing this, he certainly did not have to.
You will be waiting a longtime, sorry.
Cat's out of the bag...wait for it.
Pretty clear no dilution as you suggested, glad company was prepared to acknowledge the confusion.
“We have no intent to raise capital, or our authorized share count and/or our outstanding shares count, unless it is absolutely necessary to meet our above-mentioned goals as a company. As of right now, there is no necessity for an S-1 filing. We value and appreciate the continued support from our shareholders, and further updates on developments within our current objectives will be forthcoming.”
Total shitshow. "S-1 filing was a miscalculation on our behalf"...24 hour bipolar 180 about something that major.
Tom's always passing the buck...maybe he doesn't realize he's the CEO and he signed off on all the filings.
He's implying someone else made that decision...on RMSL's "behalf".
Tampa, FL, June 16, 2022 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, would like to address shareholders regarding the S-1 filing from June 15th, 2022.
First and foremost, we want to be clear, we did not file the S-1 out of necessity. This was set up as a precautionary safety net given the current global and U.S. economic dynamics, and the challenges they are imposing not only now, but in the future as well. With the historic rate of rising inflation and the impact it is having on interest rates, cost of materials, labor rates, and overall cost of conducting business, we felt that it may be in the best interest of the company, for the long term, to have access to a line of credit that could be used on an emergency use basis. The cost involved now is potentially far less than it could be in the future, and we thought weâ??d rather have it and not need it, than the other way around. The intent was not to exercise the S-1 unless we absolutely had to, and because of our current robust financial state, that would be well in the future, if ever. In hindsight, the decision to have a line of credit via an S-1 filing was a miscalculation on our behalf. We want to be clear on this as well, our intent is to:
- Continue to generate revenues and profits from our CPAP machine distribution agreement.
- To successfully up list to OTCQB® status.
- To obtain FDA approval on our 510k for the patented DeltaWave Nasal Pillow Mask as soon as possible.
- Upon FDA approval, to have a successful sales/marketing campaign and launch for the patented DeltaWave Nasal Pillow Mask.
- To proceed with the filing of the 510k for our 2nd CPAP mask to broaden and strengthen our product line up.
We have absolute belief in our ability to execute these objectives, and we have made the decision to terminate the S-1 filing effective immediately. We have no intent to raise capital, or our authorized share count and/or our outstanding shares count, unless it is absolutely necessary to meet our above-mentioned goals as a company. As of right now, there is no necessity for an S-1 filing. We value and appreciate the continued support from our shareholders, and further updates on developments within our current objectives will be forthcoming.
Shareholders waiting for the next shoe to drop...the cat's out of the bag about what Tom's planning on doing.
News flash: public notification required before use.
OBVIOUSLY the equity line hasn't been used since May 10th because the SEC requires them to file the S-1 before doing so.
Wait for the refiling with amendments. This has happened numerous times with RMSL for several offerings that have been filed, withdrawn, and re-filed with changes.
Withdrawing S-1...wise move:
http://archive.fast-edgar.com/20220616/A32ZF22CLW22R242222C2MY2HGMKZ222Y642/
Followers
|
311
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31338
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |